Current ideas of a complex relationship between atrial fibrillation and ischemic heart disease and of optimum tactics for anticoagulant therapy to prevent embolism in systemic circulation
The article discusses the issue of searching for optimum oral anticoagulants to prevent thrombosis and embolism induced by heart disease both in patients with atrial fibrillation and sinus rhythm. A complex bidirectional relationship between atrial fibrillation and coronary atherosclerosis is consid...
Gespeichert in:
| Veröffentlicht in: | Kardiologiia 2017-01, Vol.57 (S1), p.312-322 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng ; rus |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 322 |
|---|---|
| container_issue | S1 |
| container_start_page | 312 |
| container_title | Kardiologiia |
| container_volume | 57 |
| creator | Golshmid, M V Gilyarevskiy, S R Kuzmina, I M Sinitsina, I I |
| description | The article discusses the issue of searching for optimum oral anticoagulants to prevent thrombosis and embolism induced by heart disease both in patients with atrial fibrillation and sinus rhythm. A complex bidirectional relationship between atrial fibrillation and coronary atherosclerosis is considered along with possible mechanisms for development of myocardial infarction in patients with atrial fibrillation. The authors provided evidence-based data which can be used in selecting an anticoagulant for prevention of heart disease induced thrombosis and embolism taking into account both the efficacy and safety established in randomized clinical studies. |
| doi_str_mv | 10.18087/cardio.2399 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1980535185</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1980535185</sourcerecordid><originalsourceid>FETCH-LOGICAL-c216t-7dcfd90efcc0622f7f15fd81a1d32a79d1ee78e29aeb8ee9e1b62f4d46afacfb3</originalsourceid><addsrcrecordid>eNo9kTtv3DAQhFnYiA3bXWpjSxc5h6ROD5bGIX4ABtwktbAilzkCoiiTlJP7bflzoU9Oql1gBt_uYBj7LPit6HjXftUYjQu3slLqhJ1zLuVG8S0_Y1cpuYHzpm6rbV1_YmdSybYp2jn7s1tipCmDM4QJggUEHfw80m-INGJ2YUp7N8NA-RfRBJijwxGsG6IbVx1wMuCS3pN3GvaEMYNxqfDoKBVomLPzi4eMOjudwIZYpLIG_LmMZYO8p4jzAXKAOdLb-0vkhzC65MFNkA4pH_HaRb2sdy_ZqcUx0dXHvGA_7r993z1unl8ennZ3zxstRZM3rdHWKE5Wa95IaVsrams6gcJUEltlBFHbkVRIQ0ekSAyNtFuzbdCitkN1wW5W7hzD60Ip976kpZJ-orCkXqiO11UturpYv6xWHUNKkWw_R-cxHnrB-2NL_dpS_95SsV9_kJfBk_lv_tdP9Rc1MJhC</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1980535185</pqid></control><display><type>article</type><title>Current ideas of a complex relationship between atrial fibrillation and ischemic heart disease and of optimum tactics for anticoagulant therapy to prevent embolism in systemic circulation</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Golshmid, M V ; Gilyarevskiy, S R ; Kuzmina, I M ; Sinitsina, I I</creator><creatorcontrib>Golshmid, M V ; Gilyarevskiy, S R ; Kuzmina, I M ; Sinitsina, I I ; N. V. Sklifosovsky Research Institute of Emergency Medicine ; State Budgetary Educational Institution of Advanced Professional Education, "Russian Medical Academy of Postgraduate Education" of the Ministry of Health of the Russian Federation</creatorcontrib><description>The article discusses the issue of searching for optimum oral anticoagulants to prevent thrombosis and embolism induced by heart disease both in patients with atrial fibrillation and sinus rhythm. A complex bidirectional relationship between atrial fibrillation and coronary atherosclerosis is considered along with possible mechanisms for development of myocardial infarction in patients with atrial fibrillation. The authors provided evidence-based data which can be used in selecting an anticoagulant for prevention of heart disease induced thrombosis and embolism taking into account both the efficacy and safety established in randomized clinical studies.</description><identifier>ISSN: 0022-9040</identifier><identifier>DOI: 10.18087/cardio.2399</identifier><identifier>PMID: 29276904</identifier><language>eng ; rus</language><publisher>Russia (Federation)</publisher><subject>Anticoagulants - administration & dosage ; Anticoagulants - therapeutic use ; Atrial Fibrillation - complications ; Atrial Fibrillation - physiopathology ; Coronary Artery Disease - complications ; Coronary Artery Disease - physiopathology ; Embolism - etiology ; Embolism - prevention & control ; Humans ; Myocardial Infarction - etiology ; Myocardial Ischemia - complications ; Myocardial Ischemia - physiopathology</subject><ispartof>Kardiologiia, 2017-01, Vol.57 (S1), p.312-322</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,4025,27928,27929,27930</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29276904$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Golshmid, M V</creatorcontrib><creatorcontrib>Gilyarevskiy, S R</creatorcontrib><creatorcontrib>Kuzmina, I M</creatorcontrib><creatorcontrib>Sinitsina, I I</creatorcontrib><creatorcontrib>N. V. Sklifosovsky Research Institute of Emergency Medicine</creatorcontrib><creatorcontrib>State Budgetary Educational Institution of Advanced Professional Education, "Russian Medical Academy of Postgraduate Education" of the Ministry of Health of the Russian Federation</creatorcontrib><title>Current ideas of a complex relationship between atrial fibrillation and ischemic heart disease and of optimum tactics for anticoagulant therapy to prevent embolism in systemic circulation</title><title>Kardiologiia</title><addtitle>Kardiologiia</addtitle><description>The article discusses the issue of searching for optimum oral anticoagulants to prevent thrombosis and embolism induced by heart disease both in patients with atrial fibrillation and sinus rhythm. A complex bidirectional relationship between atrial fibrillation and coronary atherosclerosis is considered along with possible mechanisms for development of myocardial infarction in patients with atrial fibrillation. The authors provided evidence-based data which can be used in selecting an anticoagulant for prevention of heart disease induced thrombosis and embolism taking into account both the efficacy and safety established in randomized clinical studies.</description><subject>Anticoagulants - administration & dosage</subject><subject>Anticoagulants - therapeutic use</subject><subject>Atrial Fibrillation - complications</subject><subject>Atrial Fibrillation - physiopathology</subject><subject>Coronary Artery Disease - complications</subject><subject>Coronary Artery Disease - physiopathology</subject><subject>Embolism - etiology</subject><subject>Embolism - prevention & control</subject><subject>Humans</subject><subject>Myocardial Infarction - etiology</subject><subject>Myocardial Ischemia - complications</subject><subject>Myocardial Ischemia - physiopathology</subject><issn>0022-9040</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kTtv3DAQhFnYiA3bXWpjSxc5h6ROD5bGIX4ABtwktbAilzkCoiiTlJP7bflzoU9Oql1gBt_uYBj7LPit6HjXftUYjQu3slLqhJ1zLuVG8S0_Y1cpuYHzpm6rbV1_YmdSybYp2jn7s1tipCmDM4QJggUEHfw80m-INGJ2YUp7N8NA-RfRBJijwxGsG6IbVx1wMuCS3pN3GvaEMYNxqfDoKBVomLPzi4eMOjudwIZYpLIG_LmMZYO8p4jzAXKAOdLb-0vkhzC65MFNkA4pH_HaRb2sdy_ZqcUx0dXHvGA_7r993z1unl8ennZ3zxstRZM3rdHWKE5Wa95IaVsrams6gcJUEltlBFHbkVRIQ0ekSAyNtFuzbdCitkN1wW5W7hzD60Ip976kpZJ-orCkXqiO11UturpYv6xWHUNKkWw_R-cxHnrB-2NL_dpS_95SsV9_kJfBk_lv_tdP9Rc1MJhC</recordid><startdate>201701</startdate><enddate>201701</enddate><creator>Golshmid, M V</creator><creator>Gilyarevskiy, S R</creator><creator>Kuzmina, I M</creator><creator>Sinitsina, I I</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201701</creationdate><title>Current ideas of a complex relationship between atrial fibrillation and ischemic heart disease and of optimum tactics for anticoagulant therapy to prevent embolism in systemic circulation</title><author>Golshmid, M V ; Gilyarevskiy, S R ; Kuzmina, I M ; Sinitsina, I I</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c216t-7dcfd90efcc0622f7f15fd81a1d32a79d1ee78e29aeb8ee9e1b62f4d46afacfb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng ; rus</language><creationdate>2017</creationdate><topic>Anticoagulants - administration & dosage</topic><topic>Anticoagulants - therapeutic use</topic><topic>Atrial Fibrillation - complications</topic><topic>Atrial Fibrillation - physiopathology</topic><topic>Coronary Artery Disease - complications</topic><topic>Coronary Artery Disease - physiopathology</topic><topic>Embolism - etiology</topic><topic>Embolism - prevention & control</topic><topic>Humans</topic><topic>Myocardial Infarction - etiology</topic><topic>Myocardial Ischemia - complications</topic><topic>Myocardial Ischemia - physiopathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Golshmid, M V</creatorcontrib><creatorcontrib>Gilyarevskiy, S R</creatorcontrib><creatorcontrib>Kuzmina, I M</creatorcontrib><creatorcontrib>Sinitsina, I I</creatorcontrib><creatorcontrib>N. V. Sklifosovsky Research Institute of Emergency Medicine</creatorcontrib><creatorcontrib>State Budgetary Educational Institution of Advanced Professional Education, "Russian Medical Academy of Postgraduate Education" of the Ministry of Health of the Russian Federation</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Kardiologiia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Golshmid, M V</au><au>Gilyarevskiy, S R</au><au>Kuzmina, I M</au><au>Sinitsina, I I</au><aucorp>N. V. Sklifosovsky Research Institute of Emergency Medicine</aucorp><aucorp>State Budgetary Educational Institution of Advanced Professional Education, "Russian Medical Academy of Postgraduate Education" of the Ministry of Health of the Russian Federation</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Current ideas of a complex relationship between atrial fibrillation and ischemic heart disease and of optimum tactics for anticoagulant therapy to prevent embolism in systemic circulation</atitle><jtitle>Kardiologiia</jtitle><addtitle>Kardiologiia</addtitle><date>2017-01</date><risdate>2017</risdate><volume>57</volume><issue>S1</issue><spage>312</spage><epage>322</epage><pages>312-322</pages><issn>0022-9040</issn><abstract>The article discusses the issue of searching for optimum oral anticoagulants to prevent thrombosis and embolism induced by heart disease both in patients with atrial fibrillation and sinus rhythm. A complex bidirectional relationship between atrial fibrillation and coronary atherosclerosis is considered along with possible mechanisms for development of myocardial infarction in patients with atrial fibrillation. The authors provided evidence-based data which can be used in selecting an anticoagulant for prevention of heart disease induced thrombosis and embolism taking into account both the efficacy and safety established in randomized clinical studies.</abstract><cop>Russia (Federation)</cop><pmid>29276904</pmid><doi>10.18087/cardio.2399</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0022-9040 |
| ispartof | Kardiologiia, 2017-01, Vol.57 (S1), p.312-322 |
| issn | 0022-9040 |
| language | eng ; rus |
| recordid | cdi_proquest_miscellaneous_1980535185 |
| source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
| subjects | Anticoagulants - administration & dosage Anticoagulants - therapeutic use Atrial Fibrillation - complications Atrial Fibrillation - physiopathology Coronary Artery Disease - complications Coronary Artery Disease - physiopathology Embolism - etiology Embolism - prevention & control Humans Myocardial Infarction - etiology Myocardial Ischemia - complications Myocardial Ischemia - physiopathology |
| title | Current ideas of a complex relationship between atrial fibrillation and ischemic heart disease and of optimum tactics for anticoagulant therapy to prevent embolism in systemic circulation |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-12T21%3A44%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Current%20ideas%20of%20a%20complex%20relationship%20between%20atrial%20fibrillation%20and%20ischemic%20heart%20disease%20and%20of%20optimum%20tactics%20for%20anticoagulant%20therapy%20to%20prevent%20embolism%20in%20systemic%20circulation&rft.jtitle=Kardiologiia&rft.au=Golshmid,%20M%20V&rft.aucorp=N.%20V.%20Sklifosovsky%20Research%20Institute%20of%20Emergency%20Medicine&rft.date=2017-01&rft.volume=57&rft.issue=S1&rft.spage=312&rft.epage=322&rft.pages=312-322&rft.issn=0022-9040&rft_id=info:doi/10.18087/cardio.2399&rft_dat=%3Cproquest_cross%3E1980535185%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1980535185&rft_id=info:pmid/29276904&rfr_iscdi=true |